Home › Funds › a16z Capital Management, L.L.C. › ERAS
a16z Capital Management, L.L.C. position in ERAS
ERASCA INC · Health Care
a16z Capital Management, L.L.C. reported holding 2,862,500 shares of ERAS (ERASCA INC) in its Q2 2026 13F filing — a position valued at US$52.4M, representing 0.37% of its reported portfolio and ranking #8 among its reported holdings. a16z Capital Management, L.L.C. has disclosed ERAS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How a16z Capital Management, L.L.C.'s ERAS position evolved
a16z Capital Management, L.L.C. first disclosed a stake in ERAS in Q4 2023 at 2,862,500 shares (US$6.1M). The position peaked in Q2 2026 at 2,862,500 shares, worth US$52.4M. Across 11 filings, a16z Capital Management, L.L.C. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 2,862,500 shares valued at US$52.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 2.86M | $6.10M | New |
| Q1 2024 | 2.86M | $5.90M | Hold |
| Q2 2024 | 2.86M | $6.76M | Hold |
| Q3 2024 | 2.86M | $7.81M | Hold |
| Q4 2024 | 2.86M | $7.18M | Hold |
| Q1 2025 | 2.86M | $3.92M | Hold |
| Q2 2025 | 2.86M | $3.64M | Hold |
| Q3 2025 | 2.86M | $6.24M | Hold |
| Q4 2025 | 2.86M | $10.65M | Hold |
| Q1 2026 | 2.86M | $46.32M | Hold |
| Q2 2026 | 2.86M | $52.44M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ERAS and 13F data
ERAS (ERASCA INC) is a Health Care company. 78 other funds we track also report a position in ERAS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$457.5M), RTW INVESTMENTS, LP (US$328.8M), Venrock Adviser, LLC (US$327.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ERAS
- Frazier Life Sciences Management, L.P. 24.98M sh · $457.55M · Q2 2026
- RTW INVESTMENTS, LP 17.95M sh · $328.78M · Q2 2026
- Venrock Adviser, LLC 17.89M sh · $327.78M · Q2 2026
- Logos Global Management LP 12.15M sh · $222.59M · Q2 2026
- Siren, L.L.C. 11.40M sh · $208.81M · Q2 2026
- Paradigm Biocapital Advisors LP 9.55M sh · $174.96M · Q2 2026
- ARCH Venture Management, LLC 7.09M sh · $129.92M · Q2 2026
- Cormorant Asset Management, LP 6.00M sh · $109.92M · Q2 2026
- Affinity Asset Advisors, LLC 5.25M sh · $96.18M · Q2 2026
- Vivo Capital, LLC 4.13M sh · $75.61M · Q2 2026
- Soleus Capital Management, L.P. 2.70M sh · $49.46M · Q2 2026
- SAMLYN CAPITAL, LLC 2.26M sh · $41.35M · Q2 2026
More on a16z Capital Management, L.L.C.
FAQ
How long has a16z Capital Management, L.L.C. held ERAS?
a16z Capital Management, L.L.C. has disclosed ERAS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is a16z Capital Management, L.L.C.'s current position in ERAS?
As of Q2 2026, a16z Capital Management, L.L.C. holds 2.86M shares of ERAS (ERASCA INC), valued at $52.44M, representing 0.37% of its reported portfolio and ranking #8.
Has a16z Capital Management, L.L.C. been buying or selling ERAS?
In the latest 13F filing (Q2 2026), a16z Capital Management, L.L.C. held unchanged its position in ERAS. The position peaked in Q2 2026 at 2.86M shares.
Which other funds hold ERAS?
Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Venrock Adviser, LLC, among 78 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.